Loading...
OTCM
NRBP
Market cap155kUSD
Sep 10, Last price  
0.45USD
1D
0.00%
1Q
-77.50%
IPO
-99.99%
Name

Pharmagreen Biotech Inc

Chart & performance

D1W1MN
OTCM:NRBP chart
P/E
0.38
P/S
65.14
EPS
1.18
Div yield, %
Shrs. gr., 5y
-61.90%
Rev. gr., 5y
%
Revenues
2k
-29.97%
000000002,9983,4102,388
Net income
406k
P
-1,669-69,682-18,986-1,074,000-768,000-2,438,000-4,532,000-875,000-569,000-1,004,000406,363
CFO
-23k
L-17.03%
-1,669-61,107-21,081-785,534-317,832-607,634-206,081-426,568-73,838-28,086-23,304

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Pharmagreen Biotech Inc. is a biotechnology solutions provider primarily engaged in cultivating young plant stock for the medical cannabis and CBD hemp industries. Established in 2007, the company operates from its base in Coquitlam, Canada.

Key people

Peter Wojcik
President, Director, Chief Executive Officer and Director - WFS Pharmagreen Inc.and B.C. Ltd. · since 2018
Jamail Larkins
Vice President
Fawzia Afreen
Chief Operating Officer - WFS Pharmagreen Inc. · since 2018
Terry Kwan
Chief Financial Officer, Director - WFS Pharmagreen Inc. · since 2013
IPO date
Dec 12, 2008
Employees
Domiciled in
CA
Incorporated in
US
Headquarters & legal address
112 NORTH CURRY STREET
Carson City, NV 89703
US
Previous name
AIR TRANSPORT GROUP HOLDINGS, INC.

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT